Saturday, July 27, 2013

Shuanghui's Smithfield bid sparks US worries over supply of drug heparin





US lawmakers are concerned a Chinese company's planned US$4.7 billion acquisition of pork producer Smithfield Foods could affect the safety and availability of heparin, a blood-thinner widely used in heart surgery and kidney dialysis that is derived from pig intestines.









via Business feed http://www.scmp.com/business/companies/article/1291598/shuanghuis-smithfield-bid-sparks-us-worries-over-supply-drug

No comments:

Post a Comment